News

Vaxart stock climbs on positive study of pill-based norovirus vaccine
Vaxart (NASDAQ:VXRT) shares rose in post market trading on Wednesday after the company said it met its main goals in ...
Vaxart signals cash runway into Q1 2026 while advancing COVID-19 and norovirus vaccine programs
Q1 2025 Management View Steven Lo, CEO, opened by highlighting the lifting of the stop work order on the 10,000 participant ...